The Dark Secret of the MIT Science Club

Dark Secret_MIT Science Club for Children 2016 The article, published by PRICEONOMICS on April 19, 2016, is a reminder of what happened when Americans were swept up by an ideology of elitism. Orphaned children were deemed “feeble minded” and warehoused in state institutions . . . Continue reading →

Accountability Demanded – NYC Foster Children AIDS drug trials

The efforts of AHRP to hold the medical research community and government administrators accountable for unethical exploitation of vulnerable children in medical experiments conducted in violation of federal regulations. Continue reading →

Vera Institute of Justice Final Report (2009): 80 NYC Foster Children Died in AIDS Drug Trials

Background:  Between 1985 and 2005, at least 532 infants and children in New York City were conscripted as human subjects of clinical trials testing experimental AIDS drugs and vaccines. The New York City Agency for Child Services (ACS), the custodian of foster . . . Continue reading →

AIDS Drug Experiments on Foster Care Children – A National Scandal

Wed, 04 May 2005 Researchers Tested AIDS Drugs on Children, Associated Press On March 10, 2004, The Alliance for Human Research Protection filed a complaint with the FDA and the federal Office of Human Research Protection about a series of AIDS drug . . . Continue reading →

AHRP Testimonies and Presentations

AHRP Testimonies and Presentations Sep 8, 2005: AHRP Testimony: NYS Hearing –AIDS Drug /Vaccine Experiments on Foster Children July 18, 2005: Cheaper than Chimpanzees Statement by Vera Hassner Sharav before the Committee on Ethical Consideration for Revisions to DHHS Regulations on Protection . . . Continue reading →

Complaint: Phase I AIDS Drug/Vaccine Experiment on Foster Children

ALLIANCE FOR HUMAN RESEARCH PROTECTION http://www.ahrp.org 142 West End Ave. Suite 28P New York, NY 10023 March 10, 2004 Dr. Michael Carome Chief of Compliance Office of Human Research Protections David Horowitz Director, Office of Compliance Food & Drug Administration Dept. of . . . Continue reading →